BNET Industries
Last Fiscal Year Sales:$271.8K
- Public
- US
Dow Jones Description
Cementitious Materials, Inc. was originally incorporated in Idaho on May 6, 1971 as Hall Mountain Silver Mines, Inc. For a period after inception, Hall Mountain was involved in the ownership and operations of certain mining claims. Operations discontinued in 1981 and we remained inactive until approximately 1989. On June 5, 1989 we changed our name to Network Videotex Systems, Inc. and, on November 13, 1989, we changed the name to Wessex International, Inc. On May 22, 1991, we acquired Ocean Express Lines, Inc., a Florida corporation engaged in the business of operating a scheduled steamship between Miami, Florida and ports in the Western Caribbean and Gulf of Mexico. The acquisition was accounted for as a pooling of interest. In connection with the transaction, we changed its name to Ocean Express Lines, Inc. We did not achieve profitable operations and ceased operations in 1992. In 1999, Williams Investments Company prevailed in a lawsuit against Ocean Express Lines to collect certain debts owed it. Williams Investments was granted a judgment against the company in the amount of $10,000 plus interest, which judgment was converted into 13,749,824 shares of our common stock. Williams Investments is principally owned by H. Deworth Williams, currently our President and one of our directors.
Naturalnano President
Michael RiedlingerContact Information
832 Emerson St.
Rochester, New York 14613
585-267-4850
Peer Companies
NAICS Code Biological Product (except Diagnostic) Manufacturing: 325414
News & Analysis
Filter by
naturalnano inc. - All News and Analysis
Speak with other shareholders about: (OTCBB: TMEN), (OTC: RFDL), (OTCBB: NNAN), (OTC: NPYC), (OTC: HPGI).
M2 PRESSWIRE-26 March 2007-Stockwire.com: Speak with other shareholders about: (OTCBB: TMEN), (OTC: RFDL), (OTCBB: NNAN), (OTC: NPYC), (OTC: HPGI)C1994-2007 M2 COMMUNICATIONS LTD RDATE:26032007 AUSTIN - A very interesting indicator to look for is where the money is flowing into. We have...
NaturalNano, Inc. Presents A Roadmap To Commercialization Of Product, While Other Companies Gain Approval To Initiate Clinical Study, Release Financial Results, Extend Service Agreement, Announce Subsidiary News, Awarded Contract,.
M2 PRESSWIRE-23 March 2007-Stockguru.com: NaturalNano, Inc. Presents A Roadmap To Commercialization Of Product, While Other Companies Gain Approval To Initiate Clinical Study, Release Financial Results, Extend Service Agreement, Announce Subsidiary News, Awarded Contract,C1994-2007 M2 COMMUNICATIONS LTD RDATE:23032007 Dallas, Texas -...
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Michael Riedlinger | Naturalnano President |
| Cathy Fleischer | Chief Technology Officer |
| Kathleen Browne | Chief Financial Officer |
| Aaron Wagner | Director of Research and Development |
| Organization | Position | Status |
|---|---|---|
| Naturalnano, Inc. | Naturalnano President | Current |
| Organization | Position | Status |
|---|---|---|
| Naturalnano, Inc. | Chief Technology Officer | Current |
| Organization | Position | Status |
|---|---|---|
| Naturalnano, Inc. | Chief Financial Officer | Current |
| Organization | Position | Status |
|---|---|---|
| Naturalnano, Inc. | Director of Research and Development | Current |
Industry Transcripts by Seeking Alpha
-
Peregrine Pharmaceuticals Inc. F2Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Dec 10, 2009about PPHM
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- More Tysabri Problems; Time for a Biogen-Idec Credibility Check 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
- Why J&J's Stelara Launch Should Target Dermatologists First 3 votes

